Ralf Schirrmacher

Ralf Schirrmacher

University of Alberta

H-index: 45

North America-Canada

About Ralf Schirrmacher

Ralf Schirrmacher, With an exceptional h-index of 45 and a recent h-index of 25 (since 2020), a distinguished researcher at University of Alberta, specializes in the field of PET, SPECT, radiochemistry, nuclear chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide F-18-SiTATE–first clinical experiences

PET imaging in dementia: Mini-review and Canadian perspective for clinical use

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11

Radiosynthesis of Stable 198Au-Nanoparticles by Neutron Activation of αvβ3-Specific AuNPs for Therapy of Tumor Angiogenesis

Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F] SiTATE

Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update

Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin αvβ3 Targeting

Ralf Schirrmacher Information

University

Position

___

Citations(all)

5707

Citations(since 2020)

2297

Cited By

4305

hIndex(all)

45

hIndex(since 2020)

25

i10Index(all)

117

i10Index(since 2020)

75

Email

University Profile Page

Google Scholar

Ralf Schirrmacher Skills & Research Interests

PET

SPECT

radiochemistry

nuclear chemistry

Top articles of Ralf Schirrmacher

Title

Journal

Author(s)

Publication Date

PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide F-18-SiTATE–first clinical experiences

Nuklearmedizin-NuclearMedicine

S Kunte

V Wenter

GT Sheikh

M Unterrainer

S Lindner

...

2024/4

PET imaging in dementia: Mini-review and Canadian perspective for clinical use

Freimut Juengling

Frank Wuest

Ralf Schirrmacher

Jonathan Abele

Alexander Thiel

...

2024/3/4

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11

Pharmaceuticals

Benedikt Judmann

Björn Wängler

Ralf Schirrmacher

Gert Fricker

Carmen Wängler

2023/2/11

Radiosynthesis of Stable 198Au-Nanoparticles by Neutron Activation of αvβ3-Specific AuNPs for Therapy of Tumor Angiogenesis

Pharmaceuticals

Güllü Davarci

Carmen Wängler

Klaus Eberhardt

Christopher Geppert

Ralf Schirrmacher

...

2023/11/30

Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE

European Journal of Nuclear Medicine and Molecular Imaging

Marcus Unterrainer

Sophie C Kunte

Lena M Unterrainer

Adrien Holzgreve

Astrid Delker

...

2023/9

Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F] SiTATE

Frontiers in Oncology

Ralf S Eschbach

Markus Hofmann

Lukas Späth

Gabriel T Sheikh

Astrid Delker

...

2023/1/30

Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update

Carolin Jaworski

Petar Iliev

Carmen Wängler

Björn Wängler

Brent Page

...

2023/8/3

Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin αvβ3 Targeting

ACS omega

Diana Braun

Benedikt Judmann

Xia Cheng

Björn Wängler

Ralf Schirrmacher

...

2023/1/4

Silicon–Fluoride Acceptors (SiFA) for 18F-Radiolabeling: From Bench to Bedside

Lexi Gower-Fry

Carmen Wängler

Peter Bartenstein

Leonie Beyer

Simon Lindner

...

2023/11/26

[18F]TRACK, a PET tracer for imaging of tropomyosin receptor kinases (Trk): Efficient radiosynthesis and preliminary evaluation in the TgF344‐AD rat model of …

Alzheimer's & Dementia

Min Su Kang

Alexander Thiel

Ralf Schirrmacher

Vadim Bernard‐Gauthier

Carolin Jaworski

...

2023/6

CycloSiFA: Die nächste Generation von Silicium‐basierten Fluoridakzeptoren für die Positronenemissionstomographie (PET)

Angewandte Chemie

Matthias Mawick

Carolin Jaworski

Jens Bittermann

Ljuba Iovkova

Yinglan Pu

...

2023/12/11

Synthesis of a Bifunctional Cross‐Bridged Chelating Agent, Peptide Conjugation, and Comparison of 68Ga Labeling and Complex Stability Characteristics with …

ChemMedChem

Helen Damerow

Björn Wängler

Ralf Schirrmacher

Gert Fricker

Carmen Wängler

2023/1/3

Radiosynthesis of Stable [sup. 198] Au-Nanoparticles by Neutron Activation of α [sub. v] β [sub. 3]-Specific AuNPs for Therapy of Tumor Angiogenesis.

Pharmaceuticals

Güllü Davarci

Carmen Wängler

Klaus Eberhardt

Christopher Geppert

Ralf Schirrmacher

...

2023/11/1

Untersuchung von monomeren Radioliganden ausgehend von publizierten EGFR-spezifischen Peptiden hinsichtlich ihrer Eignung für die Theranostik maligner Transformationen

Nuklearmedizin-NuclearMedicine

B Judmann

B Wängler

R Schirrmacher

C Wängler

2023/4

CycloSiFA: The Next Generation of Silicon‐Based Fluoride Acceptors for Positron Emission Tomography (PET)

Angewandte Chemie International Edition

Matthias Mawick

Carolin Jaworski

Jens Bittermann

Ljuba Iovkova

Yinglan Pu

...

2023/12/11

Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [18F] SiTATE

European Journal of Nuclear Medicine and Molecular Imaging

Marcus Unterrainer

Sophie C Kunte

Lena M Unterrainer

Adrien Holzgreve

Astrid Delker

...

2023

Good practices for the automated production of 18F-SiFA radiopharmaceuticals

Simon Blok

Carmen Wängler

Peter Bartenstein

Klaus Jurkschat

Ralf Schirrmacher

...

2023/10/11

Ansätze zur Volumenbestimmung von Meningeomen in der PET/CT Bildgebung mit dem neuartigen Tracer F-18-SiTATE

Nuklearmedizin-NuclearMedicine

SC Kunte

LM Unterrainer

A Delker

S Lindner

M Brendel

...

2023/4

Fluorinated beta-hydroxybutyric acids for pet imaging

2023/12/5

Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases

EJNMMI research

Melinda Wuest

Justin J Bailey

Jennifer Dufour

Darryl Glubrecht

Vanessa Omana

...

2022/7/30

See List of Professors in Ralf Schirrmacher University(University of Alberta)

Co-Authors

academic-engine